$104.53
-0.96 (-0.91%)
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Price Target
Analyst Price Target
-70.3% upside
Low Target
$20.33
Average Target
$31.03
High Target
$33.62
Current Price
$104.53
Current
$104.53
$104.53
Target
$31.03
$31.03
$20.33
$31.03 avg
$33.62
Scenario Analysis
Bear Case
$20.33
-80.6%
Low target
Base Case
$31.03
-70.3%
Avg target
Bull Case
$33.62
+-67.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$130.05
-19.6% from high
52-Week Low
$36.65
+185.2% from low
50-Day SMA
$78.66
+32.9% vs SMA
200-Day SMA
$56.03
+86.6% vs SMA
RSI (14)
77.3
Overbought
Target vs 52W High
$31.03
-76.1% vs high
Next Earnings Report
Aug 10, 2026
2d
until earnings
EPS Est: $-0.73
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +5.4% |
| AMGN | Hold | 43 | 49% | $190.87 | -52.7% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +179.1% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -9.5% |
| REGN | Buy | 38 | 71% | $76.80 | -90.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -42.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -46.0% |
| BIIB | Buy | 44 | 64% | $91.45 | -55.7% |